Home Biotechnology Clexio Biosciences
C

Clexio Biosciences

Profile managed by Bizz Id
Israel 11-50 employees 2018
Biotechnology
Claim this profile

Description

Clinical-stage Israeli pharmaceutical company founded in 2018. Focused on rapid-onset treatments for neurological and psychiatric disorders. CLE-100 (NMDA antagonist) in Phase 2 for major depression. Pipeline for Parkinson's and pain.

Contact company

Register for free to see this company’s contact details and get in touch.

Register - Free

We only use technical cookies that are necessary for the site to work and to keep you signed in. We do not use analytics or advertising cookies. Cookies